Literature DB >> 4259631

The physiological disposition of 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.

M Chadwick, W I Rogers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4259631

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  21 in total

1.  Depletion of nuclear actin is a key mediator of quiescence in epithelial cells.

Authors:  Virginia A Spencer; Sylvain Costes; Jamie L Inman; Ren Xu; James Chen; Michael J Hendzel; Mina J Bissell
Journal:  J Cell Sci       Date:  2011-01-01       Impact factor: 5.285

Review 2.  Selective uptake and retention of anticancer agents by sensitive cells.

Authors:  D L Hill; J A Montgomery
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 3.  The practical benefits of pharmacokinetics in the use of antineoplastic agents.

Authors:  C Erlichman; R C Donehower; B A Chabner
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  Neuropathologic study on chronic neurotoxicity of 5-fluorouracil and its masked compounds in dogs.

Authors:  R Okeda; T Karakama; S Kimura; S Toizumi; T Mitsushima; Y Yokoyama
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

Review 5.  Cellular pharmacology of fluorinated pyrimidines in vivo in man.

Authors:  J S Kovach; R W Beart
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

Review 6.  The fluoropyrimidines: biochemical mechanisms and design of clinical trials.

Authors:  M A Friedman; W Sadée
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

7.  Effect of concurrent calcium leucovorin infusion on 5-fluorouracil cytotoxicity against murine L1210 leukemia.

Authors:  P Klubes; I Cerna; M A Meldon
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

8.  Nonlinear pharmacokinetics for the elimination of 5-fluorouracil after intravenous administration in cancer patients.

Authors:  B J McDermott; H W van den Berg; R F Murphy
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

9.  Pharmacokinetics of 5-fluorouracil: inter-relationship with biochemical kinetics in monitoring therapy.

Authors:  W Sadee; C G Wong
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

10.  Comparison of the bioavailability of uridine in mice after either oral or parenteral administration.

Authors:  P Klubes; D B Geffen; R L Cysyk
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.